The majority of Republicans (62%) disapprove and support repealing the law.

More than 8 in 10 say regulatory pressures are affecting their costs and margins, according to new research from HealthEdge.

Ninety-five percent of CEOs surveyed are optimistic about the coming year, and 84% expect economic conditions to improve.

The American Hospital Association and Maine Hospital Association on Monday filed a lawsuit in U.S. District Court in Maine to stop upcoming changes to the federal 340B Drug Pricing Program.

Judge Quraishi ruled that the connection between premiums paid by plan participants and out-of-pocket costs and the administrative fees the plans paid to their pharmacy benefit manager was “speculative.”

Only 6 in 10 employees feel satisfied with their benefit offerings, compared to two-thirds in the previous year.

“Far too many people who need obesity treatments still face cost and coverage barriers,” said Ilya Yuffa, executive vice president of Lilly USA.

The transaction completes UnitedHealth’s efforts since 2022 to exit is South American ventures.